Pharmaceuticals(42)

  • Anti-QSOX1 Antibody for Treating Cancer and Metastasis (No. T4-1642)

    Cancer, and especially cancer metastasis, is a leading cause of death worldwide. Research in recent years highlighted the importance of the extracellular matrix (ECM) surrounding the tumor in cancer progression metastasis formation. ... Read more
    Full Professor Deborah Fass

    Deborah Fass

    Faculty of Chemistry

    5560
  • Biological Treatment for Pancreatic Cancer (MMP7 mAb) (No. T4-1640)

    The innovative concept leading to this high selectivity is immunization with both a synthetic metal-protein mimicry molecule, previously developed by the present inventors, followed by the metalloenzyme itself (e.g. MMP-7). ... Read more
    Full Professor Irit Sagi

    Irit Sagi

    Faculty of Biology

    5557
  • A TACE Inhibitor (ADAM17) (No. T4-1628)

    New generation of superior nature-inspired therapeutics for treating inflammation.Inflammation is characterized by elevated levels of TNF-?. Neutralizing TNF-? ... Read more
    Full Professor Irit Sagi

    Irit Sagi

    Faculty of Biology

    5551
  • SiRNA Proteasome Inhibitors for Cancer Theraphy (No. T4-1619)

    Triple negative breast cancer (TNBC) is an aggressive type of breast cancer, representing over 10% of all breast cancer cases. TNBC is known for its high risk of relapse, poor survival prospects, and near zero survival rates once TNBC metastasizes. ... Read more
    Emeritus Yosef Shaul

    Yosef Shaul

    Faculty of Biochemistry

    5548
  • MicroRNA Differental Profiles as ALS Biomarkers (No. T4-1498)

    Associate Professor Eran Hornstein

    Eran Hornstein

    Faculty of Biochemistry

    5488
  • Inhibition of Nuclear Entry of MAPK Cascade Proteins as a Novel Mechanism for Treating Cancer (No. T4-1446)

    Peptide sequences for efficient inhibition of nuclear translocation of proteins. ... Read more
    Full Professor Rony Seger

    Rony Seger

    Faculty of Biology

    5473
  • CD84 - a Novel Regulator of B-CLL Survival (No. T4-1441)

    Chronic lymphocytic leukemia (CLL), a malignant disease characterized by the accumulation of B lymphocytes in the blood, lymphoid organs, and bone marrow, is the second most common type of leukemia in adults, accounting for about 7,000 new cases of leukemia each year. ... Read more
    Full Professor Idit Shachar

    Idit Shachar

    Faculty of Biology

    5470
  • Monoclonal Anti-Ubiquitinated Histone H2B Antibody (No. T4-1397)

    A novel antibody which can be used, for the first time, to recognize ubiquitinated histone 2B. This technology is novel in its ability to recognize proteins and their destinations, and may serve in diagnostics and immunoprecipitation processes. ... Read more
    Extension Service Moshe Oren

    Moshe Oren

    Faculty of Biology

    5464
  • On-Chip Synthesis of Biomolecules (No. T4-1369)

    Cell-free synthetic platforms that enable complex biological activities such as synthesis and self-assembly of biomolecules, can be employed for various applications, including drug discovery and diagnostics. ... Read more
    Full Professor Roy Bar-Ziv

    Roy Bar-Ziv

    Faculty of Chemistry

    5455
  • A biological drug (PAS- YNS8) for cancer therapy (No. T4-1360)

    The human type I interferons number 12 distinct non-allelic alpha proteins, one beta, and one omega, all sharing the same structure and binding the same two cell surface receptors, IFNAR1 and IFNAR2. ... Read more
    Full Professor Gideon Schreiber

    Gideon Schreiber

    Faculty of Biochemistry

    5827

Pages

Subscribe to Pharmaceuticals